In 2024, Lotus Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Lotus Pharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Lotus Pharmaceutical’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
In 2024, the total operational greenhouse gas (GHG) emissions of Lotus Pharmaceutical amounted to 15,515.044 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Lotus Pharmaceutical increased by 0.49%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
In 2024, the total Scope 1 emissions of Lotus Pharmaceutical were 2,672.054 metric tons of CO₂ equivalent (tCO₂e). a
Since 2022, Lotus Pharmaceutical's Scope 1 emissions have decreased by 74.94%, reflecting a declining long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2023), Lotus Pharmaceutical's Scope 1 emissions decreased by 19.28%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
In 2024, Lotus Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 12,842.99 tCO₂e without specifying the calculation method. a
Since 2022, Lotus Pharmaceutical's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 20.63%, reflecting a rising long-term trend in Scope 2 emissions over time. a
Compared to the previous year (2023), Lotus Pharmaceutical's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Lotus Pharmaceutical 's emissions have plateaued with no significant change in its energy consumption footprint. a
In 2024, Lotus Pharmaceutical reported its Scope 2 emissions using an unspecified methodology. a